Cardio Diagnostics Holdings Inc. Share Price

Cardio Diagnostics Holdings Inc. Share Price

NASDAQ: CDIO | Micro Cap
$1.75
-$0.08 (-4.37%) Last updated on 18 Nov, 2026 | 02:19 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Cardio Diagnostics Holdings Inc. Stock Performance

Open
$1.71
Prev. Close
$1.83
Circuit Range
N/A
Day Range
$1.71 - $1.71
Year Range
$0.97 - $7.89
Volume
131
Average Traded
$1.71

Cardio Diagnostics Holdings Inc. Share Price Today

As of 18 November 2026, Cardio Diagnostics Holdings Inc.'s share price is $1.75. The stock opened at $1.71, compared to its previous close of $1.83. During today's trading session, Cardio Diagnostics Holdings Inc.'s share price traded between $1.71 and $1.71, with an average price of $1.71. Over the past 52 weeks, the stock has recorded a high of $7.89 and a low of $0.97. In terms of performance, Cardio Diagnostics Holdings Inc.'s share price has declined by 5.91% over the last six months and is down 41.86% on a year-on-year basis.

Cardio Diagnostics Holdings Inc. Share Price Chart

Line chart of the Cardio Diagnostics Holdings Inc. price trend over the selected period. The price fell overall, ranging from 1.71 to 1.77, ending at 1.75.
$1.71$1.71
L
Show Current Price
H

Cardio Diagnostics Holdings Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.06M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.19
Revenue (TTM)
$10.00M
Return On Equity (TTM)
-113.45%
Profit Margin
-65000.00%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-17.69%

Cardio Diagnostics Holdings Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.01$0.00
Net Profit-$1.47-$1.79-$1.50-$1.73
Net Profit MarginN/AN/A-15000.00%N/A
Income ChangeN/A-21.77%16.20%-15.33%

Cardio Diagnostics Holdings Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.02$0.03$0.01
Net Profit-$4.66-$8.38-$8.38-$6.50
Net Profit MarginN/A-41900.00%-27933.33%-65000.00%
Income ChangeN/A-79.83%0.00%22.43%

About Cardio Diagnostics Holdings Inc.

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.

Cardio Diagnostics Holdings Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.65
$1.71
+0.59%
Oct 2026
$1.89
$1.70
-11.46%
Sep 2026
$1.85
$1.92
+3.78%
Aug 2026
$1.60
$1.85
+17.46%
Jul 2026
$2.20
$1.57
-28.08%
Jun 2026
$1.93
$2.19
+17.74%
May 2026
$1.78
$1.86
+3.91%
Apr 2026
$2.02
$1.79
-8.67%
Mar 2026
$5.39
$1.96
-69.75%
Feb 2026
$1.47
$6.48
+332.00%
Jan 2026
$2.84
$1.50
-48.19%
Dec 2025
$2.90
$2.90
-3.82%

CDIO Share Price FAQs